SCHEMBL22011377

SCHEMBL22011377

c1ccc(-n2c3ccccc3c3c4ccc5oc6ccccc6c5c4c4c5ccccc5oc4c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 4/20 0.39
PPARG P37231 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
NR2E3 Q9Y5X4 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
POLB P06746 2/20 0.37
MEN1 O00255 2/20 0.37
TSHR P16473 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 2/20 0.37
BRCA1 P38398 1/20 0.37
LMNA P02545 2/20 0.36
CA9 Q16790 3/20 0.35
CA12 O43570 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HCRTR1 O43613 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011964 0.91 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL22011531 0.91 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL22011378 0.90 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL22011975 0.88 ALDH1A1 (0.37) KDM4EALDH1A1PPARGRXFP1NR2E3
SCHEMBL22011373 0.88 ALDH1A1 (0.32) KDM4EALDH1A1PPARGRXFP1NR2E3
SCHEMBL22011968 0.88 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL19986016 0.87 KDM4E (0.44) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL22011970 0.87 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL24171792 0.87 MAPK1 (0.36) KDM4EATML3MBTL1ALDH1A1PPARG
SCHEMBL17246188 0.87 KDM4E (0.47) KDM4EATML3MBTL1ALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 KDM4E 1792/4885ATM 1787/4885L3MBTL1 2301/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 KDM4E 1792/4885ATM 1787/4885L3MBTL1 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.